ARCHIVES
VOL. 8, ISSUE 1 (2023)
Exploring the medicinal properties of Strobilanthes jomyi: A pharmacognostic, phytochemical, and pharmacological investigation
Authors
Dr. Juan Pérez, Dr. Ana Martínez, Dr. Ricardo Gómez
Abstract
The medicinal properties of Strobilanthes jomyi were explored
through pharmacognostic, phytochemical, and pharmacological investigations to
validate its traditional uses. Pharmacognostic analysis revealed distinct
microscopic and macroscopic features for the authentication of the plant.
Phytochemical screening identified key bioactive compounds, including
quercetin, rutin, gallic acid, and volatile compounds such as phytol and
linoleic acid. These compounds were quantitatively analyzed using HPLC and
GC-MS, with results indicating notable antioxidant and anti-inflammatory
activities. The antioxidant potential, assessed via DPPH and ABTS assays,
revealed significant radical scavenging activity, with IC50 values of 42.6
µg/mL and 36.9 µg/mL, respectively. In vivo, S. jomyi demonstrated a
dose-dependent reduction in paw edema, achieving a 67.3% inhibition at 200
mg/kg, similar to the effects of the standard drug, diclofenac sodium. These
findings suggest that S. jomyi is a promising candidate for the
development of natural antioxidants and anti-inflammatory agents, warranting
further research into its bioactive components and mechanisms of action.
Pages:36-38
How to cite this article:
Dr. Juan Pérez, Dr. Ana Martínez, Dr. Ricardo Gómez "Exploring the medicinal properties of <i>Strobilanthes jomyi</i>: A pharmacognostic, phytochemical, and pharmacological investigation". International Journal of Research in Pharmacy and
Pharmaceutical Sciences, Vol 8, Issue 1, 2023, Pages 36-38
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.